Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Dow
Medtronic
Merck
US Army
Covington
Cerilliant
Cipla

Generated: June 21, 2018

DrugPatentWatch Database Preview

LIPO GANTRISIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Lipo Gantrisin patents expire, and when can generic versions of Lipo Gantrisin launch?

Lipo Gantrisin is a drug marketed by Roche and is included in one NDA.

The generic ingredient in LIPO GANTRISIN is sulfisoxazole acetyl. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole acetyl profile page.
Summary for LIPO GANTRISIN
Drug patent expirations by year for LIPO GANTRISIN
Synonyms for LIPO GANTRISIN
4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide
80-74-0
AC1L1N11
AC1Q6V7X
Acetamide, N-((4-aminophenyl)sulfonyl)-N-(3,4-dimethyl-5-isoxazolyl)-
Acetamide, N-(3,4-dimethyl-5-isoxazolyl)-N-sulfanilyl-
Acetamide, N-[(4-aminophenyl)sulfonyl] -N-(3,4-dimethyl-5-isoxazolyl)-
Acetamide, N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5-isoxazolyl)-
ACETYL SULFISOXAZOLE
acetylsulfafurazole
Acetylsulfisoxazole
Acetylsulfisoxazole (JAN)
AK481301
AKOS027427029
AN-24034
API0004283
B4954
C14H16N2O4S
CAS-80-74-0
CHEBI:135975
CHEMBL1200910
D05956
DSSTox_CID_3620
DSSTox_GSID_23620
DSSTox_RID_97551
DTXSID4023620
EINECS 201-305-3
HE060616
HE390844
JFNWFXVFBDDWCX-UHFFFAOYSA-N
KS-000001H6
Lipo gantrisin (TN)
LS-177521
MolPort-006-147-734
N-((4-Aminophenyl)sulfonyl)-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-(3,4-Dimethyl-5-isoxazolyl)-N-sulfanilylacetamide
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide
N-(4-aminophenyl)sulfonyl-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5- isoxazolyl)acetamide
N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethylisoxazol-5-yl)acetamide
N-3,4-DIMETHYLISOXAZOL-5-YL-N-SULFANILYLACETAMIDE
N-3,4-Dimethylisoxazol-5-yl-N-sulphanilylacetamide
N-Acetyl-4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #
NCGC00249884-01
SCHEMBL41727
Sulfisoxazole acetal
Sulfisoxazole acetyl
Sulfisoxazole acetyl (USP)
Sulfisoxazole acetyl [USAN]
Sulfisoxazole acetyl [USP]
SULFISOXAZOLEACETYL(200MG)
Tox21_113660
UNII-WBT5QH3KED
WBT5QH3KED
ZINC2114

US Patents and Regulatory Information for LIPO GANTRISIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche LIPO GANTRISIN sulfisoxazole acetyl EMULSION;ORAL 009182-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
McKinsey
Baxter
Federal Trade Commission
Teva
Cantor Fitzgerald
Queensland Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.